Free Trial
→ Porter flew 3,300 miles to investigate this system (From Porter & Company) (Ad)tc pixel Free SCLXW Stock Alerts

Scilex (SCLXW) Competitors

Scilex logo
$0.13 -0.01 (-10.00%)
Closing price 05/22/2026 03:35 PM Eastern
Extended Trading
$0.14 +0.01 (+8.73%)
As of 05/22/2026 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

SCLXW vs. SXTPW, ACONW, AIMDW, DRTSW, and ALVOW

Should you buy Scilex stock or one of its competitors? MarketBeat compares Scilex with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Scilex include 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), and Alvotech (ALVOW). These companies are all part of the "medical" sector.

How does Scilex compare to 60 Degrees Pharmaceuticals?

Scilex (NASDAQ:SCLXW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scilex$33.86MN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
ScilexN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

In the previous week, Scilex had 1 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 1 mentions for Scilex and 0 mentions for 60 Degrees Pharmaceuticals. Scilex's average media sentiment score of 0.84 beat 60 Degrees Pharmaceuticals' score of 0.00 indicating that Scilex is being referred to more favorably in the media.

Company Overall Sentiment
Scilex Positive
60 Degrees Pharmaceuticals Neutral

Summary

Scilex beats 60 Degrees Pharmaceuticals on 3 of the 3 factors compared between the two stocks.

How does Scilex compare to Aclarion?

Aclarion (NASDAQ:ACONW) and Scilex (NASDAQ:SCLXW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations, institutional ownership and media sentiment.

Company Net Margins Return on Equity Return on Assets
AclarionN/A N/A N/A
Scilex N/A N/A N/A

In the previous week, Scilex had 1 more articles in the media than Aclarion. MarketBeat recorded 1 mentions for Scilex and 0 mentions for Aclarion. Scilex's average media sentiment score of 0.84 beat Aclarion's score of 0.00 indicating that Scilex is being referred to more favorably in the news media.

Company Overall Sentiment
Aclarion Neutral
Scilex Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$77.88KN/AN/AN/AN/A
Scilex$33.86MN/AN/AN/AN/A

Summary

Scilex beats Aclarion on 3 of the 3 factors compared between the two stocks.

How does Scilex compare to Ainos?

Scilex (NASDAQ:SCLXW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

Company Net Margins Return on Equity Return on Assets
ScilexN/A N/A N/A
Ainos N/A N/A N/A

In the previous week, Scilex had 1 more articles in the media than Ainos. MarketBeat recorded 1 mentions for Scilex and 0 mentions for Ainos. Scilex's average media sentiment score of 0.84 beat Ainos' score of 0.00 indicating that Scilex is being referred to more favorably in the media.

Company Overall Sentiment
Scilex Positive
Ainos Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scilex$33.86MN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

Summary

Scilex beats Ainos on 3 of the 3 factors compared between the two stocks.

How does Scilex compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Scilex (NASDAQ:SCLXW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, media sentiment, institutional ownership and valuation.

In the previous week, Scilex had 1 more articles in the media than Alpha Tau Medical. MarketBeat recorded 1 mentions for Scilex and 0 mentions for Alpha Tau Medical. Scilex's average media sentiment score of 0.84 beat Alpha Tau Medical's score of 0.00 indicating that Scilex is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Tau Medical Neutral
Scilex Positive

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Scilex N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
Scilex$33.86MN/AN/AN/AN/A

Summary

Scilex beats Alpha Tau Medical on 3 of the 3 factors compared between the two stocks.

How does Scilex compare to Alvotech?

Scilex (NASDAQ:SCLXW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scilex$33.86MN/AN/AN/AN/A
Alvotech$586.32MN/AN/AN/AN/A

In the previous week, Scilex had 1 more articles in the media than Alvotech. MarketBeat recorded 1 mentions for Scilex and 0 mentions for Alvotech. Scilex's average media sentiment score of 0.84 beat Alvotech's score of 0.00 indicating that Scilex is being referred to more favorably in the media.

Company Overall Sentiment
Scilex Positive
Alvotech Neutral

Company Net Margins Return on Equity Return on Assets
ScilexN/A N/A N/A
Alvotech N/A N/A N/A

Summary

Scilex beats Alvotech on 2 of the 3 factors compared between the two stocks.

Get Scilex News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCLXW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SCLXW vs. The Competition

Export
MetricScilexDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$75.02B$6.46B$12.34B
Dividend YieldN/A2.40%2.76%5.28%
P/E RatioN/A25.0620.9925.66
Price / SalesN/A148.89559.5886.31
Price / CashN/A16.2543.4956.67
Price / BookN/A3.5810.447.14
Net IncomeN/A$3.18B$3.57B$335.98M
7 Day Performance-21.25%-0.61%6.37%4.11%
1 Month Performance-22.22%-2.79%3.51%2.52%
1 Year PerformanceN/A22.33%34.10%35.04%

Scilex Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SCLXW
Scilex
N/A$0.13
-10.0%		N/A+29.5%$0.00$33.86MN/A105
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
+0.8%		N/AN/A$0.00$1.01MN/A2
ACONW
Aclarion
N/A$0.03
-11.0%		N/A+4.7%$0.00$75.73KN/A7
AIMDW
Ainos
N/A$0.08
+11.1%		N/A-71.2%$0.00$18.11KN/A40
DRTSW
Alpha Tau Medical
N/A$2.69
+19.6%		N/AN/A$0.00N/AN/A80

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SCLXW) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...
Eagle Publishing | Sponsoredtc pixel
The S-1 just dropped. 22 days left.
The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...
Behind the Markets | Sponsoredtc pixel
My crisis of conscience
Emmet Savage - named in Irish America's Wall Street 50 as one of the most successful investors in the world - ...
Porter & Company | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
Skip the Line Opportunity: The SpaceX IPO
Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...
Brownstone Research | Sponsoredtc pixel
FINAL HOURS: $9 Income ETF Access VANISHES at MIDNIGHT
Tim Plaehn's income ETF research is available at 82% off - but only until midnight tonight. This Memorial Day ...
Investors Alley | Sponsoredtc pixel